Harnessing the antiplatelet effects of prostaglandin E2 by EP3 receptor blockade

被引：0
|
作者：
Iyu, D. [1 ]
Heptinstall, S. [1 ]
机构：
[1] Univ Nottingham, Cardiovasc Med, Nottingham, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-MO-101
引用
收藏
页码：350 / 351
页数：2
相关论文
共 50 条
  • [1] Antagonists of the EP3 Receptor for Prostaglandin E2 Are Novel Antiplatelet Agents That Do Not Prolong Bleeding
    Singh, Jasbir
    Zeller, Wayne
    Zhou, Nian
    Hategen, Georgeta
    Mishra, Rama
    Polozov, Alex
    Yu, Peng
    Onua, Emmanuel
    Zhang, Jun
    Zembower, David
    Kiselyov, Alex
    Ramirez, Jose L.
    Sigthorsson, Gudmundur
    Bjornsson, Jon Mar
    Thorsteinsdottir, Margret
    Andresson, Thorkell
    Bjarnadottir, Maria
    Magnusson, Olafur
    Fabre, Jean-Etienne
    Stefansson, Kari
    Gurney, Mark E.
    ACS CHEMICAL BIOLOGY, 2009, 4 (02) : 115 - 126
  • [2] The EP3 receptor for prostaglandin E2 in peripheral arterial disease
    Bjarnadottir, Maria
    Andresson, Thorkell
    Gudmundsson, Kolbeinn
    Gurney, Mark
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E109 - E109
  • [3] Modulation of platelet aggregation by the EP3 receptor for prostaglandin E2
    Athirakul, K
    Thomas, DW
    Fabre, JE
    Koller, B
    Coffman, TM
    HYPERTENSION, 2000, 36 (04) : 721 - 721
  • [4] Prostaglandin E2 EP3 receptor modulation of insulin secretion in diabetes
    Ceddia, Ryan P.
    Gannon, Maureen
    Breyer, Richard M.
    FASEB JOURNAL, 2013, 27
  • [5] Prostaglandin E2 Mediates Cough Via the EP3 Receptor.
    Maher, S. A.
    Birrell, M. A.
    Belvisi, M. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [6] Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor
    Gu, Xiaosong
    Xu, Jiang
    Zhu, Liping
    Bryson, Timothy
    Yang, Xiao-Ping
    Peterson, Edward
    Harding, Pamela
    CIRCULATION-HEART FAILURE, 2016, 9 (08)
  • [7] Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor
    Gu, Xiaosong
    Xu, Jiang
    Yang, Xiao-Ping
    Peterson, Edward
    Harding, Pamela
    CIRCULATION RESEARCH, 2015, 117
  • [8] DG-041, a novel antiplatelet agent, is a potent and selective antagonist of the EP3 receptor for prostaglandin E2
    Singh, Jasbir
    Andresson, Thorkell
    Ramirez, Jose
    Zeller, Wayne
    Gurney, Mark
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E80 - E80
  • [9] The deleterious role of the prostaglandin E2 EP3 receptor in angiotensin II hypertension
    Bryson, Timothy D.
    Pandrangi, Teja S.
    Khan, Safa Z.
    Xu, Jiang
    Pavlov, Tengis S.
    Ortiz, Pablo A.
    Peterson, Edward
    Harding, Pamela
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2020, 318 (04): : H867 - H882
  • [10] INHIBITION OF PROSTAGLANDIN E2 RECEPTOR EP3 PROTECTS AFTER INTRACEREBRAL HEMORRHAGE
    Han, X.
    Lan, X.
    Li, Q.
    Gao, Y.
    Cheng, T.
    Wang, J.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 : 353 - 354
12345